When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Última revisão: 20 Mar 2025
Última atualização: 09 Feb 2024

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • presença de fatores de risco
  • obstrução do intestino delgado
  • pigmentação mucocutânea

Outros fatores diagnósticos

  • desconforto e distensão abdominal
  • dor abdominal
  • hemorragia digestiva
  • prolapso de pólipo perianal
  • testículo aumentado (sem massas)
  • ginecomastia bilateral
  • fadiga
  • palidez

Fatores de risco

  • história familiar positiva
  • mutação das linhas germinativas no gene STK11

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • endoscopia
  • enterografia por ressonância magnética
  • histologia do pólipo
  • teste genético para STK11

Algoritmo de tratamento

Colaboradores

Autores

Luke Engelking, MD

Associate Professor of Internal Medicine

UT Southwestern Medical Center

Dallas

TX

Declarações

LE is a Principal Investigator for, and has received grant support from, the National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases (NIH-NIDDK) and the Cancer Prevention and Research Institute of Texas.

Po-Hong Liu, MD

Fellow

UT Southwestern Medical Center

Dallas

TX

Declarações

PL declares that he has no competing interests.

Agradecimentos

Dr Luke Engelking and Dr Po-Hong Liu would like to gratefully acknowledge Dr Brandie Heald, Dr James Church, and Dr Carol A. Burke, previous contributors to this topic.

Declarações

BH declares that she has received payment from the following but has no contractual agreement to disseminate product information for them: Speakers Bureau Myriad Genetics Lab, and the advisory board for Invitae. BH is also President of the Collaborative Group of the Americas on Inherited Colorectal Cancer, for which she does not receive payment. JC declares that he has no competing interests. CAB receives research support from Cancer Prevention Pharmaceuticals.

Revisores

Daniel Von Allmen, MD

Chief of Pediatric Surgery

University of North Carolina

Chapel Hill

NC

Declarações

DVA declares that he has no competing interests.

Patrick Morrison, MD

Consultant in Clinical Genetics

Department of Medical Genetics

Belfast HSC Trust

Belfast

UK

Declarações

PM declares that he has no competing interests.

O uso deste conteúdo está sujeito ao nosso aviso legal